市场调查报告书
商品编码
1439342
眼科黏弹性器材 (OVD) - 全球市场考量、竞争格局、市场预测 (2030)Ophthalmic Viscoelastic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
预计2023年全球眼科黏弹性器械(OVD)市场规模将达25亿美元,到2030年将达到32.1亿美元,2024-2030年预测期间复合年增长率为4.23%。由于白内障和青光眼等眼病患病率上升、技术进步以及人口老化迅速增加,预计该市场将会成长。
眼科黏弹性器材 (OVD) 市场动态
眼科黏弹性装置(OVD)市场已显着扩大,因为它多年来一直用于眼内手术以保护眼睛内的脆弱结构。这些设备的使用对白内障手术、青光眼手术和玻璃体视网膜手术等手术具有重大意义。根据世界卫生组织(WHO)2022年的统计,至少有22亿人有近视或远视。在全球范围内,这些人中至少有 10 亿(几乎一半)患有可预防或未经治疗的视力丧失。视力丧失和失明的主要原因是未矫正的白内障。因此,眼科疾病和手术患者的快速增加正在促进全球眼科黏弹性装置(OVD)市场的成长。
此外,新技术的进步也达到了一个高峰。例如,2022年4月,Bausch + Lomb宣布美国食品药物管理局(FDA)已批准其ClearVisc™可分散眼科黏弹性装置(OVD)用于眼科手术。该装置在眼科手术期间可以非常有效地保护角膜。眼科黏弹性器械(OVD)领域的此类技术进步可能会推动全球眼科黏弹性器械(OVD)市场的发展。
此外,根据《世界人口展望World Population Prospects(2019)》,2019年全球65岁以上人口为7.03亿。此外,根据最近的一项研究《2020年全球人口老化报告Global Population Aging 2020 Report》(联合国,2020),人口老化正以惊人的速度成长。2020年,全球65岁以上人口约为7.27亿人。到 2050 年,此类患者的数量预计将增加一倍,达到 15 亿。因此,随着老年人口的增加,老年人眼睛患白内障的可能性也会增加,这反过来又促进了全球眼科黏弹性装置(OVD)市场的成长。
除上述因素外,由于为遏制 COVID-19 传播而实施的封锁措施,眼科黏弹性器械 (OVD) 市场经历了暂时的衰退。这段时间的主要措施之一是暂停许多择期手术和门诊。受此影响,封城初期各医疗科室大量手术暂停,导致市场对眼科黏弹器械(OVD)的需求减少,从而短期限制了市场成长。话虽如此,眼科黏弹性器材(OVD)市场正处于復苏阶段,由于世界各地多种 COVID-19 疫苗的批准和管理,包括医疗保健服务在内的各个领域的活动都已恢復。
眼科黏弹性器材 (OVD) 细分市场分析
以眼科黏弹性器械(OVD)市场的类型细分,复合眼科黏弹性器械细分市场预计将占据全球眼科黏弹性器械(OVD)市场的主要份额。该产品领域的巨大市场份额归因于越来越多的患者采用这些设备。
眼科黏弹性材料可以具有分散性和内聚性。在手术过程中,保护角膜内皮是一种分散特性,在囊膜脱离过程中压平水晶体前囊是一种内聚特性。对于许多外科医生来说,使用复合眼科黏弹性材料可以两全其美,因为它们可以用作整个手术的专用黏弹性材料。此类药物的例子包括 DiscoVisc (Alcon) 和 Amvisc Plus (B&L),这两种药物都旨在成为适合常规病例的单注射药物。
本报告提供了全球眼科黏弹性器材(OVD)市场的研究和分析,包括市场规模和预测、驱动因素和挑战、公司和产品概况。
Ophthalmic Viscoelastic Devices Market By Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic), By Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others), And By End-User (Hospitals, Ophthalmology Clinics, Others), by geography, is expected to grow at a steady CAGR forecast till 2030 owing to the technological advancements and surge in the geriatric population
Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.50 billion in 2023, growing at a CAGR of 4.23% during the forecast period from 2024 to 2030, to reach USD 3.21 billion by 2030. The Ophthalmic Viscoelastic Devices market is expected to witness growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.
Ophthalmic Viscoelastic Devices Market Dynamics:
Ophthalmic Viscoelastic Devices (OVDs) Market has significantly increased due to the fact that for many years, Ophthalmic Viscoelastic Devices have been used in intraocular surgery to protect delicate structures inside the eyes. The use of these devices has major significance during procedures like cataract surgeries, glaucoma surgeries, vitreoretinal surgeries. As per World Health Organization 2022, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion - or almost half - of these cases, vision impairment could have been prevented or has yet to be addressed globally. The leading causes of vision impairment and blindness are uncorrected cataracts. Thus, the burgeoning cases of ophthalmic conditions and surgeries will contribute to the Global Ophthalmic Viscoelastic Devices Market growth.
In addition, the advancement of new technologies is advancing at a great peak. For instance, in April 2022, Bausch + Lomb announced that the US Food and Drug Administration (FDA) approved ClearVisc(TM) dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. The device offers exceptional corneal protection during ophthalmic surgery. Such technological advancement in the field of Ophthalmic Viscoelastic Devices is likely to boost the Global Ophthalmic Viscoelastic Devices Market.
Furthermore, as per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally. Moreover, as per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure for such patients is expected to double and reach 1.5 billion by 2050. Therefore, as the aging population increases, there will be more chances of the older population getting cataracts in their eyes, which will eventually boost the growth of the Global Ophthalmic Viscoelastic Devices market.
Along with the above-mentioned factors, the Ophthalmic Viscoelastic Devices market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Ophthalmic Viscoelastic Devices in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Ophthalmic Viscoelastic Devices is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Ophthalmic Viscoelastic Devices market during the forecast period.
Ophthalmic Viscoelastic Devices Market Segment Analysis:
Ophthalmic Viscoelastic Devices Market By Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic), by Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others), Ophthalmic Viscoelastic Devices Market by End-User (Hospitals, Ophthalmology Clinics, Others), and Ophthalmic Viscoelastic Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Ophthalmic Viscoelastic Devices market tye segment, the Combination Ophthalmic Viscoelastic market segment will hold the major share of the Global Ophthalmic Viscoelastic Devices market. The large market share of this product segment can be attributed to the growing patient adoption of these devices.
Combination Ophthalmic Viscoelastic may have some dispersive properties as well as some cohesive properties. Protecting the corneal endothelium throughout the surgery is a dispersive characteristic while flattening the anterior lens capsule during capsulorhexis is a cohesive attribute. For many surgeons, using a Combination of Ophthalmic Viscoelastic has the best of both as they can use it as the exclusive viscoelastic for the entire surgery. Examples of these agents include DiscoVisc (Alcon) and Amvisc Plus (B&L), both of which aim to be good single-syringe agents for routine cases.
Realizing that two separate OVDs offer more versatility than a single agent, companies offer dual-viscoelastic systems, which incorporate a dispersive OVD and a cohesive OVD in separate syringes which are known as Dual OVD Packages. These can be opened together, though they are not packaged as such.
Therefore, Combination Ophthalmic Viscoelastic Devices are gaining commercial acceptability, which improves market penetration. All these advantages of these devices make physicians more inclined to use Combination Ophthalmic Viscoelastic.
Hence, all the above-mentioned factors are expected to drive the segment growth of the Ophthalmic Viscoelastic Devices market.
North America is expected to dominate the overall Global Ophthalmic Viscoelastic Devices Market:
North America is expected to dominate the overall Ophthalmic Viscoelastic Devices market during the forecast period. This domination is due to the rising number of cataract surgeries, and other ophthalmic surgeries in the region. As per the Journal of Cataract Refract Surgeries 2020, the volume of cataract surgeries performed per year has increased steadily over the past few decades in the United States.
Additionally, according to Cancer Vision 2020, based on the trends in the surgical volume of cataract surgery over the past decade, 3.7 million cataract cases would have been performed in 2020 in the United States among Medicare beneficiaries. Thus, the burgeoning cases of cataract surgeries will contribute to the growth of the Ophthalmic Viscoelastic Devices Market in the region as the demand will increase.
Further, in North America, the market is supported by developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government and increase prevalence and incidence of surgeries as mentioned above.
Europe and Asia-Pacific region have the future potential growth for the Global Ophthalmic Viscoelastic Devices market. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Ophthalmic Viscoelastic Devices market. For instance, in May 2020 BVI announced the acquisition of the ophthalmic viscoelastic device (OVD) assets from Croma, an Austrian-based company. In addition to the acquisition of existing products, BVI and Croma have embarked on an R&D collaboration on additional products that will come to market in the future. Such initiatives are anticipated to boost the Ophthalmic Viscoelastic Devices Market.
Ophthalmic Viscoelastic Devices Market Key Players:
Some of the key market players operating in the Global Ophthalmic Viscoelastic Devices Market include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc., Anika Therapeutics, Inc. among others.
Recent Developmental Activities in the Ophthalmic Viscoelastic Devices Market:
In June 2022, Rayner announced that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. This acquisition helped Rayner to rapidly bring its strong pipeline of innovative intraocular lenses (IOLs), ophthalmic viscoelastic devices (OVDs), and dry eye drop solutions to surgeons and patients across India, and further develop its global presence.
In April 2022, Bausch + Lomb announced that the FDA has approved its ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.
Key Takeaways from the Ophthalmic Viscoelastic Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Ophthalmic Viscoelastic Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Ophthalmic Viscoelastic Devices Market.
Various opportunities are available for the other competitor in the Ophthalmic Viscoelastic Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Ophthalmic Viscoelastic Devices market growth in the coming future?
Target Audience who can be benefited from this Ophthalmic Viscoelastic Devices Market Ket Report Study
Ophthalmic Viscoelastic Devices providers
Research organizations and consulting companies
Ophthalmic Viscoelastic Devices related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Ophthalmic Viscoelastic Devices
Various End-users want to know more about the Ophthalmic Viscoelastic Devices Market and the latest technological developments in the Ophthalmic Viscoelastic Devices market.
Frequently Asked Questions for Ophthalmic Viscoelastic Devices Market:
Ophthalmologists use ophthalmic viscoelastic devices (OVDs) in multiple eye operations, such as cataract surgery, glaucoma surgery, among others. These devices help secure the fragile eye structures along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.
Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.50 billion in 2023, growing at a CAGR of 4.23% during the forecast period from 2024 to 2030, to reach USD 3.21 billion by 2030.
The major drivers driving the demand for Ophthalmic Viscoelastic Devices are the growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.
Some of the key market players operating in the Ophthalmic Viscoelastic Devices market include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc. Anika Therapeutics, Inc., and others.
North America is expected to dominate the overall global Ophthalmic Viscoelastic Devices market during the forecast period from 2024 to 2030. This domination is due to the rising number of cataract surgeries, and other ophthalmic surgeries in the region.